{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:58:54Z","timestamp":1791388734440,"version":"4.3.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,17]]},"DOI":"10.7759\/cureus.26026","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T08:26:50Z","timestamp":1655454410000},"source":"Crossref","is-referenced-by-count":1,"title":["Coagulation Abnormalities and Risk Assessment in Acute Promyelocytic Leukemia: An Experience From a Resource-Constraint Country"],"prefix":"10.7759","author":[{"given":"Warkha","family":"Thakur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quratul Ain","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munira","family":"Borhany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping","volume":"1","author":"Drexler HG","year":"1987","unstructured":"Drexler HG. Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping. Leukemia. 1987, 1:697-705.","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2011.067","article-title":"History of acute promyelocytic leukemia: a tale of endless revolution","volume":"3","author":"Lo-Coco F","year":"2011","unstructured":"Lo-Coco F, Cicconi L. History of acute promyelocytic leukemia: a tale of endless revolution. Mediterr J Hematol Infect Dis. 2011, 3:e2011067. 10.4084\/MJHID.2011.067","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.10736.1","article-title":"Recent advances in acute promyelocytic leukaemia","volume":"6","author":"Ng CH","year":"2017","unstructured":"Ng CH, Chng WJ. Recent advances in acute promyelocytic leukaemia. F1000Res. 2017, 6:1273. 10.12688\/f1000research.10736.1","journal-title":"F1000Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.15406\/htij.2017.04.00079","article-title":"Clinico hematological profile of acute promyelocytic leukemia","volume":"4","author":"Sunil KP","year":"2017","unstructured":"Sunil KP, Devi S, Fatima JL. Clinico hematological profile of acute promyelocytic leukemia. Hematol Transfus Int J. 2017, 4:52-5. 10.15406\/htij.2017.04.00079","journal-title":"Hematol Transfus Int J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-84842009000800013","article-title":"Coagulation abnormalities in acute promyelocytic leukemia","volume":"31","author":"Jacomo RH","year":"2009","unstructured":"Jacomo RH, Rego EM. Coagulation abnormalities in acute promyelocytic leukemia. Rev Bras Hematol Hemoter. 2009, 31:48-50. 10.1590\/S1516-84842009000800013","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2014.04.005","article-title":"The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years","volume":"27","author":"Kwaan HC","year":"2014","unstructured":"Kwaan HC, Cull EH. The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years. Best Pract Res Clin Haematol. 2014, 27:11-8. 10.1016\/j.beha.2014.04.005","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0139-4","article-title":"Management of patients with acute promyelocytic leukemia","volume":"32","author":"Kayser S","year":"2018","unstructured":"Kayser S, Schlenk RF, Platzbecker U. Management of patients with acute promyelocytic leukemia. Leukemia. 2018, 32:1277-94. 10.1038\/s41375-018-0139-4","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022006980","article-title":"CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition","author":"Wang C","year":"2022","unstructured":"Wang C, Wang Y, Zuo N, Fang S, Shi J. CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition. Blood Adv. 2022, 10.1182\/bloodadvances.2022006980","journal-title":"Blood Adv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.12.011","article-title":"Outcomes in adult acute promyelocytic leukemia: a decade experience","volume":"20","author":"Yedla RP","year":"2020","unstructured":"Yedla RP, Bala SC, Pydi VR, et al.. Outcomes in adult acute promyelocytic leukemia: a decade experience. Clin Lymphoma Myeloma Leuk. 2020, 20:e158-64. 10.1016\/j.clml.2019.12.011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-01-894980","article-title":"Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet","volume":"133","author":"Sanz MA","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS, et al.. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019, 133:1630-43. 10.1182\/blood-2019-01-894980","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3747\/co.21.2183","article-title":"A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults","volume":"21","author":"Seftel MD","year":"2014","unstructured":"Seftel MD, Barnett MJ, Couban S, et al.. A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults. Curr Oncol. 2014, 21:234-50. 10.3747\/co.21.2183","journal-title":"Curr Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2019.12.001","article-title":"Follow-up and outcome of the twelve-year experience in adult patients with acute promyelocytic leukemia","volume":"43","author":"Steffenello-Durigon G","year":"2021","unstructured":"Steffenello-Durigon G, Bigolin A, Moraes AC, Rudolf-Oliveira RC, Moral JA, Santos-Silva MC. Follow-up and outcome of the twelve-year experience in adult patients with acute promyelocytic leukemia. Hematol Transfus Cell Ther. 2021, 43:21-7. 10.1016\/j.htct.2019.12.001","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-736686","article-title":"Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab","volume":"129","author":"Abaza Y","year":"2017","unstructured":"Abaza Y, Kantarjian H, Garcia-Manero G, et al.. Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood. 2017, 129:1275-83. 10.1182\/blood-2016-09-736686","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijh.ijh_16_18","article-title":"Acute promyelocytic leukemia: epidemiology, clinical presentation, and outcome over a 10-year period of follow-up at Nanakali Hospital of Erbil city \"single-center study\"","volume":"8","author":"Ahmed AT","year":"2019","unstructured":"Ahmed AT, Yassin AK, Mohammed NS, Hasan KM. Acute promyelocytic leukemia: epidemiology, clinical presentation, and outcome over a 10-year period of follow-up at Nanakali Hospital of Erbil city \"single-center study\". Iraqi J Hematol. 2019, 8:7-13. 10.4103\/ijh.ijh_16_18","journal-title":"Iraqi J Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.12.006","article-title":"Outcomes for patients with acute promyelocytic leukemia in South Africa","volume":"21","author":"Shein R","year":"2021","unstructured":"Shein R, Mashigo N, du Toit CE, Oosthuizen J, Seftel MD, Louw VJ, Verburgh E. Outcomes for patients with acute promyelocytic leukemia in South Africa. Clin Lymphoma Myeloma Leuk. 2021, 21:e348-52. 10.1016\/j.clml.2020.12.006","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2019.08.006","article-title":"Outcomes of high-risk acute promyelocytic leukemia patients treated with arsenic trioxide (ATO)\/all trans retinoic acid (ATRA) based induction and consolidation without maintenance phase: a case Series","volume":"13","author":"Shah G","year":"2020","unstructured":"Shah G, Mikhail FM, Bachiasvili K, Vachhani P, Erba HP, Papadantonakis N. Outcomes of high-risk acute promyelocytic leukemia patients treated with arsenic trioxide (ATO)\/all trans retinoic acid (ATRA) based induction and consolidation without maintenance phase: a case Series. Hematol Oncol Stem Cell Ther. 2020, 13:143-6. 10.1016\/j.hemonc.2019.08.006","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005642","article-title":"Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States","volume":"6","author":"Bewersdorf JP","year":"2022","unstructured":"Bewersdorf JP, Prozora S, Podoltsev NA, et al.. Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States. Blood Adv. 2022, 6:376-85. 10.1182\/bloodadvances.2021005642","journal-title":"Blood Adv"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2018.1470069","article-title":"Characteristics of fibrinolytic disorders in acute promyelocytic leukemia","volume":"23","author":"Wang P","year":"2018","unstructured":"Wang P, Zhang Y, Yang H, et al.. Characteristics of fibrinolytic disorders in acute promyelocytic leukemia. Hematology. 2018, 23:756-64. 10.1080\/10245332.2018.1470069","journal-title":"Hematology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12636","article-title":"A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia","volume":"39","author":"Shahmarvand N","year":"2017","unstructured":"Shahmarvand N, Oak JS, Cascio MJ, et al.. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia. Int J Lab Hematol. 2017, 39:375-83. 10.1111\/ijlh.12636","journal-title":"Int J Lab Hematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2019.02.007","article-title":"The value of FDP\/FIB and D-dimer\/FIB ratios in predicting high-risk APL-related thrombosis","volume":"79","author":"Bai Y","year":"2019","unstructured":"Bai Y, Shi M, Yang X, et al.. The value of FDP\/FIB and D-dimer\/FIB ratios in predicting high-risk APL-related thrombosis. Leuk Res. 2019, 79:34-7. 10.1016\/j.leukres.2019.02.007","journal-title":"Leuk Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.11.004","article-title":"Real-life outcomes on acute promyelocytic leukemia in Brazil - early deaths are still a problem","volume":"19","author":"Silva WF Jr","year":"2019","unstructured":"Silva WF Jr, Rosa LI, Marquez GL, et al.. Real-life outcomes on acute promyelocytic leukemia in Brazil - early deaths are still a problem. Clin Lymphoma Myeloma Leuk. 2019, 19:e116-22. 10.1016\/j.clml.2018.11.004","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2020.06.017","article-title":"Prevalence and outcomes of thrombotic and hemorrhagic complications in pediatric acute promyelocytic leukemia in a tertiary Brazilian center","volume":"43","author":"de Albuquerque Antunes A","year":"2021","unstructured":"de Albuquerque Antunes A, Breviglieri CN, Celeste DM, Garanito MP, Cristofani LM, Carneiro JD. Prevalence and outcomes of thrombotic and hemorrhagic complications in pediatric acute promyelocytic leukemia in a tertiary Brazilian center. Hematol Transfus Cell Ther. 2021, 43:309-12. 10.1016\/j.htct.2020.06.017","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01747.x","article-title":"Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia","volume":"88","author":"Chang H","year":"2012","unstructured":"Chang H, Kuo MC, Shih LY, et al.. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia. Eur J Haematol. 2012, 88:321-8. 10.1111\/j.1600-0609.2011.01747.x","journal-title":"Eur J Haematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S144438","article-title":"Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia","volume":"10","author":"Song YH","year":"2017","unstructured":"Song YH, Peng P, Qiao C, Zhang R, Li JY, Lu H. Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia. Onco Targets Ther. 2017, 10:4917-24. 10.2147\/OTT.S144438","journal-title":"Onco Targets Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1581187","article-title":"Predictors of early hemorrhage in acute promyelocytic leukemia","volume":"60","author":"Naymagon L","year":"2019","unstructured":"Naymagon L, Moshier E, Tremblay D, Mascarenhas J. Predictors of early hemorrhage in acute promyelocytic leukemia. Leuk Lymphoma. 2019, 60:2394-403. 10.1080\/10428194.2019.1581187","journal-title":"Leuk Lymphoma"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2020.1799969","article-title":"Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia","volume":"32","author":"Chu T","year":"2021","unstructured":"Chu T, Wang H, Lv X, et al.. Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia. Platelets. 2021, 32:677-83. 10.1080\/09537104.2020.1799969","journal-title":"Platelets"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.05.022","article-title":"Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia","volume":"35","author":"Kim DY","year":"2011","unstructured":"Kim DY, Lee JH, Lee JH, et al.. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia. Leuk Res. 2011, 35:152-8. 10.1016\/j.leukres.2010.05.022","journal-title":"Leuk Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.30.6.884","article-title":"Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia","volume":"30","author":"Lee HJ","year":"2015","unstructured":"Lee HJ, Kim DH, Lee S, et al.. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia. Korean J Intern Med. 2015, 30:884-90. 10.3904\/kjim.2015.30.6.884","journal-title":"Korean J Intern Med"},{"key":"ref29","article-title":"Acute promyelocytic leukemia: clinico-demographic profile","author":"Altaf N","year":"2018","unstructured":"Altaf N, Khan S, Abdullah K, Gul L. Acute promyelocytic leukemia: clinico-demographic profile. Int J Pathol. 2018, 123-6.","journal-title":"Int J Pathol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2014105","article-title":"Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centre","volume":"55","author":"Karim F","year":"2014","unstructured":"Karim F, Shaikh U, Adil SN, Khurshid M. Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centre. Singapore Med J. 2014, 55:443-7. 10.11622\/smedj.2014105","journal-title":"Singapore Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/94709-coagulation-abnormalities-and-risk-assessment-in-acute-promyelocytic-leukemia-an-experience-from-a-resource-constraint-country","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:58Z","timestamp":1707507958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/94709-coagulation-abnormalities-and-risk-assessment-in-acute-promyelocytic-leukemia-an-experience-from-a-resource-constraint-country"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.26026","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,17]]}}}